Categories

Smiths Medical Recalls NORMOFLO Irrigation Fluid Warmers and Warming Sets Due to the Possibility of Harmful Levels of Aluminum Leaching into the Fluid Path of the Warmers

Smiths Medical ASD Inc is recalling the NORMOFLO Irrigation Fluid Warmer and Warmers Sets because of the potential for aluminum ions leaching into warmed fluids.

http://www.fda.gov/medical-devices/medical-device-recalls/smiths-medical-recalls-normoflo-irrigation-fluid-warmers-and-warming-sets-due-possibility-harmful

 
Categories

Urgent Voluntary Recall: Level 1 Fast Flow Fluid Warming System, NORMOFLO Fluid Warmer and Level 1 Normothermic I.V. Fluid Administration Set

Level 1® Fast Flow Fluid Warming System, NORMOFLO® Fluid Warmer and Level 1® Normothermic I.V. Fluid Administration Set manufactured by Smiths Medical ASD Inc.

http://www.fda.gov/vaccines-blood-biologics/recalls-biologics/urgent-voluntary-recall-level-1-fast-flow-fluid-warming-system-normoflo-fluid-warmer-and-level-1

 
Categories

Fallecimientos relacionados al COVID-19 aumentaron en casi 40%: en promedio se registran 27 decesos diarios

Fallecimientos relacionados al COVID-19 aumentaron en casi 40%: en promedio se registran 27 decesos diarios

Primera semana de septiembre se convierte en la segunda con mayor cantidad de casos COVID-19Martes 14 de setiembre, 2021. La semana del 5 al 11 setiembre contabilizó 187 decesos relacionados al COVID-19...

https://www.ministeriodesalud.go.cr/index.php/centro-de-prensa/noticias/746-noticias-2021/2168-fallecimientos-relacionados-al-covid-19-aumentaron-en-casi-40-en-promedio-se-registran-27-decesos-diarios

 
Categories

Jacobus Pharmaceutical Company Inc. Issues Voluntary Worldwide Recall of Ruzurgi® (amifampridine) 10 mg Tablets Due to Yeast, Mold, and Bacterial Contamination

Plainsboro, New Jersey, Jacobus Pharmaceutical Company Inc. is voluntarily recalling 3 lots of Ruzurgi® (amifampridine) 10 mg tablets to the consumer level. The products have been found to be contaminated with yeast, mold, and aerobic bacteria based on laboratory test results. Oral products heavily

http://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/jacobus-pharmaceutical-company-inc-issues-voluntary-worldwide-recall-ruzurgir-amifampridine-10-mg